Agoracom Blog Home

Posts Tagged ‘AIML’

Revolutionizing Healthcare: AIML Innovations and the AI Wave

Posted by Brittany McNabb at 11:02 AM on Friday, December 29th, 2023

As the curtains draw on 2023, the enthralling narrative of the intersection between artificial intelligence (AI) and healthcare takes center stage. This macro-level review encapsulates a year of transformative developments, and AIML Innovations emerges as a key player in the dynamic landscape of AI-driven healthcare advancements.

Industry Outlook and AIML Innovations Trajectory:

The overarching positive trends in AI’s impact on healthcare lay a promising foundation. Within this trajectory, AIML Innovations distinguishes itself as a catalyst, strategically positioned to harness AI’s potential for revolutionary changes in the healthcare sector.

AIML Innovations Highlights:

As we delve into the transformative crossroads of AI and healthcare, AIML Innovations emerges with a series of remarkable achievements encapsulated in its highlights. 

Partnered with $78 Billion Eyewear Giant:

AIML Innovations forged a strategic alliance with a colossal $78 billion eyewear giant, Luxottica. This collaboration opens doors to unprecedented opportunities in the global eyewear market, positioning AIML at the forefront of technological advancements in augmented reality eyewear.


Launched Personalized AI-powered Health Advisor:

Unveiling a groundbreaking addition to its repertoire, AIML introduced a Personalized AI-powered Health Advisor. This innovative tool empowers individuals with tailored health insights, marking a significant stride in personalized healthcare solutions.


Received funding to participate in Europe’s Largest Prevention of Loss of Autonomy in Elderly Study:

AIML Innovations secured funding to actively contribute to Europe’s Largest Prevention of Loss of Autonomy in Elderly Study. This venture not only underscores AIML’s commitment to societal well-being but also positions the company as a key player in pioneering studies addressing critical healthcare challenges.


Entered Agreement with World Weight Loss to develop AI-powered weight loss avatar & app:

In a strategic move towards holistic well-being, AIML entered into a promising agreement with World Weight Loss. This collaboration aims to develop an AI-powered weight loss avatar and app, showcasing AIML’s versatility in addressing diverse aspects of health through cutting-edge technology.

AI-Powered Digital Health Platform Accelerating Momentum in Global Markets:

AIML’s proprietary AI-Powered Digital Health Platform is not merely a technological marvel; it’s a global force. Accelerating momentum in markets worldwide, AIML’s platform stands as a testament to the company’s ability to drive transformative changes in healthcare practices on a global scale.

Real-world Relevance:

Bridging the gap between cutting-edge technology and real-world impact, AIML Innovations’ contributions become tangible. Analogies and relatable examples weave a narrative that communicates the direct, positive influence AIML’s innovations have on healthcare practices, ensuring investors grasp the practical implications.

Looking Ahead with AIML Innovations:

Peering into the future, AIML Innovations doesn’t just ride the wave; it steers it. The company’s forward-looking goals seamlessly align with the optimistic industry forecast presented in the macro-level article. AIML emerges not only as an observer but a proactive driver of healthcare’s next chapter.


In a landscape pulsating with possibilities, AIML Innovations emerges as a key protagonist, poised to redefine the contours of healthcare through AI. This isn’t merely a review of the past year; it’s an invitation to investors to delve deeper into AIML’s journey. As the industry continues its metamorphosis, AIML stands as a compelling participant, beckoning investors to explore the boundless potential within its visionary endeavors.



Visit $AIML 5 Minute Research Profile On AGORACOM:

Visit $AIML Official Verified Discussion Forum On AGORACOM:

Watch $AIML Videos On AGORACOM YouTube Channel:


This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”) is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on, its related websites (;; and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

Tech2heal Partners with Leading Virtual Occupational Health Clinics in a Stride Towards Mental Health and Sleep Disorder Prevention

Posted by Brittany McNabb at 8:51 AM on Thursday, November 9th, 2023


AI/ML Innovations Inc. continues to make waves in the realm of Artificial Intelligence/Machine Learning technologies. Their subsidiary, Tech2heal, has recently entered a strategic partnership with a leading French company specializing in virtual occupational health clinics. This alliance aims to address critical aspects of employee well-being, with a particular focus on mental health and sleep disorders. The implications of this partnership extend beyond mere business collaboration; it heralds a profound shift in the approach to mental health and sleep disorders in the workplace, a topic of growing importance in the modern professional landscape.

A Pioneering Approach to Workplace Well-Being

Tech2heal’s venture into the realm of mental health and sleep disorder prevention represents a pioneering approach to addressing the well-being of employees. By joining forces with a prominent French health service provider, Tech2heal’s versatile AI-powered clinical care platform, Alakin, is poised to play a pivotal role in redefining how companies approach these critical issues. This innovative collaboration is fueled by the desire to enhance employee well-being in an ever-evolving workplace environment.

The Power of Tech2heal’s Alakin Platform

The key to this transformative partnership is Tech2heal’s Alakin platform, a powerful AI-driven solution known for its adaptability. Alakin’s capacity to create highly customizable, hybrid care pathways provides a strong foundation for addressing the unique needs of each corporate client. By streamlining care pathways and offering a user-friendly interface, Alakin ensures a seamless experience for both patients and healthcare practitioners.

Accelerating Market Adoption

The alliance between Tech2heal and the French health service provider is set to expedite the introduction of innovative employee risk prevention solutions to the market. This acceleration is a response to the growing demand for mental health and sleep disorder solutions, highlighting the timeliness and relevance of this partnership.

A Comprehensive Approach

The collaboration equips the Partner with a comprehensive suite of healthcare tools, addressing the needs of patients and healthcare practitioners. This holistic approach underscores the commitment to considering every facet of employee well-being, from mental health to sleep disorders.

Shifting Priorities in Workplace Health

Paul Duffy, CEO of AIML, emphasizes that mental health issues and sleep disorders have a substantial impact on employee productivity and organizational costs. This alliance signifies a shift in attitudes towards prioritizing the well-being of employees and marks a positive step towards proactive management of mental health and sleep disorders in the workplace.

The partnership between Tech2heal and the undisclosed French health service provider is more than a business collaboration; it is a symbol of changing attitudes and priorities in the modern workplace. As mental health and sleep disorders take center stage in discussions of employee well-being, the alliance sets a transformative precedent. Tech2heal’s Alakin platform and the Partner’s innovative solutions combine to create a powerful force dedicated to enhancing the lives of employees. This visionary approach to workplace well-being exemplifies the company’s commitment to using AI-driven technologies to address societal needs, with a keen focus on improving the health and well-being of individuals in the professional world.

As AI/ML Innovations Inc. continues to make strides in the world of Artificial Intelligence and Machine Learning, their foray into healthcare management solutions reflects a broader trend of technology-driven well-being and precision support. This partnership exemplifies a new era where the health of employees takes center stage in corporate priorities. It’s a welcome shift, and one that could have far-reaching implications for the future of the workplace and the well-being of its employees.

View original release:

Tech2Heal Chosen for International Clinical Trial Funded by European Commission

Posted by Brittany McNabb at 8:40 AM on Wednesday, October 18th, 2023


Tech2Heal SAS, a subsidiary of AI/ML Innovations Inc., has marked a significant milestone by securing its second clinical trial contract for the “My Health Friend” project. This groundbreaking initiative, a collaborative effort between French and Italian University Hospitals, is funded by a European Commission fund. The project aims to revolutionize preventative healthcare, targeting populations in remote areas with limited access to in-person healthcare services.

At the core of this pioneering endeavor is Tech2Heal’s proprietary Alakin Platform, a versatile care pathway builder. The platform will support the My Health Friend mobile health application, available in English, French, and Italian, breaking down language barriers and ensuring accessibility for a wide demographic.

This innovative application empowers users with personalized digital rehabilitation programs tailored to their specific needs, enhancing their well-being. Additionally, the Alakin clinical dashboard enables healthcare teams to remotely monitor patients, maintaining a high standard of care regardless of geographical distance.

The trial’s primary objectives include gathering data on user satisfaction and usage levels, with a focus on the general population across the transalpine territories of France and Italy. The trial will encompass 1000-1500 individuals over an 18-month period, ensuring robust and comprehensive results. Furthermore, the trial aims to assess the impact of the application on participants’ well-being and quality of life over a 6-month period.

This collaboration between Tech2Heal, French and Italian University Hospitals, and the European Commission represents a significant step forward in leveraging technology for improved healthcare accessibility and outcomes, particularly in regions with limited access to traditional healthcare services. The “My Health Friend” project is poised to make a lasting impact on preventative healthcare practices.

View Original Release:

VIDEO – AI/ML Innovations $AIML $AIMLF set to Make Waves w/ Health Gauge Partnership, U.S. Launch for AI Rx $ $ $

Posted by AGORACOM at 3:09 PM on Tuesday, October 26th, 2021
AI/ML Innovations Inc.

AI/ML Innovations is capitalizing on the burgeoning areas of artificial intelligence (AI), cloud computing and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space.

Its key subsidiary, Health Gauge, is a leading digital health solutions provider that’s disrupting the traditional healthcare industry by providing AI innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.

Its patent-pending solution is a bespoke personal health monitoring and management system, combining the latest wearable health monitors with sophisticated software tools.

Health Gauge provides for a secure and trusted means for clients to engage clinical resources and health coaching as a regular part of their care process and ongoing health management. Its robust, real-time data capture capability provides fast feedback, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.

In addition to Health Gauge, AI/ML also has a strategic partner in Tech2Heal, a France-based global provider of proprietary digital mental health and wellness products.

In late September, AI/ML announced that it had completed its transaction to acquire a significant interest in Tech2Heal (dba Tech2Health), and that Tech2Heal was readying its remote patient monitoring platform for deployment.

Now, AI/ML Innovations & Tech2Heal’s AI Rx joint venture is preparing for imminent launch into the U.S. market, with a basket of wellness and health-tech products and services designed to improve an individual’s mental health and well-being, and utilizing a unique blend of proprietary digital assets, remote live counselling, and a physical wellness center.

We caught up with Tim Daniels, AI/ML’s Executive Chairman, to discuss the firm’s progress…

Leaders of Apple, Hapbee, AI/ML $ $FIRZF and Garmin Excited About New Growth Opportunities in Booming Wearable Technologies Market $ $ $

Posted by AGORACOM at 2:04 PM on Wednesday, April 7th, 2021
AI/ML Innovations Inc.

NEW YORK, April 06, 2021 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Apple Inc. (NASDAQ: AAPL), Hapbee Technologies (OTC: HAPBF) (TSX.V: HAPB), Garmin Ltd. (NASDAQ: GRMN) and AI/ML Innovations (CSE: AIML).

The wearable tech market is projected to grow from nearly $27 billion in 2019 to $64 billion by 2024, according to a recent report by GlobalData. The growing popularity of the Internet of Things (IoT), connected devices and growing mainstream consumer adoption is driving demand. Whether it’s health monitoring by senior citizens, or activity tracking by millennial fitness enthusiasts, and “biohackers” – the wearable tech market is exploding. Wall Street Reporter highlights the latest comments from industry thought leaders:

AI/ML Innovations (CSE: AIML) Chairman, Tim Daniels: “More HealthTech M&A in Pipeline…”
AI/ML Innovations (CSE: AIML) was recently a featured presenter at Wall Street Reporter’s Investors Discovery Day livestream event. AIML Chairman Tim Daniels shared with investors the company’s innovative wearable healthtech platform which uses AI and machine learning for applications ranging from remote patient monitoring, to fitness/health tracking and more.

With an initial focus on large B2B contracts, including insurance providers, AIML is now capitalizing on growing consumer demand for its wearables, which it is marketing through online direct-to-consumer channels. Tim Daniels also updated investors on AIML’s growing pipeline of M&A opportunities in the HealthTech space, which could have a positive impact on maximizing shareholder value in coming months.
Watch AI/ML Innovations (CSE: AIML) Investors Discovery Day Video:

Read More:

AI/ML’s $ $FIRZF Health Gauge Partners with My Viva to Address Metabolic Rehabilitation $ $ $

Posted by AGORACOM at 9:26 AM on Tuesday, April 6th, 2021
AI/ML Innovations Inc.

– A realtime, actionable solution using Health Gauge’s AI-powered wearables –

TORONTO, ON / April 6, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its subsidiary, Health Gauge, has developed a strategic partnership with My Viva Plan (“MVP”) designed to effectively leverage the two companies’ collective strengths and core assets, in order to best serve digital wellness market interests at the enterprise level.

Collectively, Health Gauge and MVP have created and implemented a strategy to address Metabolic Rehabilitation, with a comprehensive program that helps patients with certain chronic illnesses to understand and harness risk factors such as obesity, high blood glucose levels, high blood pressure, and more, thus mitigating the risk of diabetes, heart disease and stroke.

“Following the launch of Health Gauge’s comprehensive wearable solution, AIML is positioning to participate in the US$58 billion wearables market in a significant way,” said Tim Daniels, Executive Chairman of AI/ML Innovations Inc.

“Additionally, the digital therapeutics market for the rehabilitation of Metabolic Disorder is growing rapidly. Health Gauge’s AI-driven digital health monitoring solution, in tandem with MVP’s individualized care plans and personal health assessments, which is supported by professional care providers and dieticians, is a uniquely powerful combination poised to disrupt this industry.”

Read More:

VIDEO – AI/ML Innovations $ $FIRZF Pens Partnerships for Health Gauge, Eyeing FDA Approval for Stateside Launch $ $ $

Posted by AGORACOM-JC at 8:57 AM on Thursday, April 1st, 2021
AI/ML Innovations Inc.

AI/ML Innovations is capitalizing on the burgeoning areas of artificial intelligence (AI) and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space.

Its key subsidiary, Health Gauge, is a leading digital health solutions provider that’s poised to disrupt the traditional healthcare industry by providing AI innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.

Its patent-pending solution is a bespoke personal health monitoring & management system, combining the latest wearable health monitors with sophisticated software tools.

Health Gauge has now secured three key strategic partnerships to assist it in addressing FDA requirements for entry into the U.S. marketplace: Zi Medical, MedStack & Privacy Horizon

With their support, Health Gauge can penetrate the $245bn global digital health monitoring market, continuing its strategy of partnering with leading channel partners, health benefits providers and end-users, via its proprietary combination of:

  • digital health monitoring devices,
  • AI-based software, and
  • cloud computing platform.

The company also completed over-subscribed strategic financing for total gross proceeds of $3m. So it is firing on all cylinders!

Make time to watch this one over the long weekend. Tim Daniels, AI/ML Innovations’ Executive Chairman, breaks it all down:

AI/ML’s $ $FIRZF Health Gauge Prepares for Entry into US Marketplace $ $ $

Posted by AGORACOM at 9:24 AM on Tuesday, March 30th, 2021
AI/ML Innovations Inc.

TORONTO, ON / ACCESSWIRE / March 30, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its subsidiary, Health Gauge, has secured key strategic partnerships to help ensure that it scales its market opportunities and enhances its ability to effectively satisfy growing product demand.

Specifically, these partnerships are intended to assist Health Gauge in addressing FDA requirements for entry into the US marketplace, as well as implementation of the most stringent of data management privacy and security standards, as Health Gauge looks towards international expansion.

“Health Gauge views the entry into the US health and wellness space as a logical and critical near-term milestone” said Tim Daniels, Executive Chairman of AI/ML.

“In order to garner requisite approvals and the utmost of confidence in Health Gauge’s portfolio of products and services by retail users, channel partners, enterprise level clients and governmental regulators, Health Gauge is utilizing the resources of industry leading partners who have the expertise to help ensure that we expeditiously and effectively meet and exceed the highest of industry standards.”

Read More:

AI/ML’s $ $FIRZF Health Gauge Launches Its e-Commerce Website for Digital Health Wearables $ $ $

Posted by AGORACOM at 11:53 AM on Thursday, March 18th, 2021
AI/ML Innovations Inc.

TORONTO, ON / March 18, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its subsidiary, Health Gauge, has launched its e-commerce platform for the retail sale of its proprietary wearable, digital health solution.

Health Gauge’s patent pending, wellness solution empowers the user by utilizing three integrated components: a selection of Health Gauge’s branded wearable health monitors, Health Gauge’s AI-powered phone app (Apple and Android), and Health Gauge’s subscription-based cloud computing platform, which seamlessly combine to provide the user and their health service providers with immediate, meaningful and actionable information and feedback, resulting in better health recovery outcomes and the achievement of healthier living objectives for the user.

“This is a significant milestone, as our data-driven health solution achieves commercialization” said Randy Duguay, CEO of Health Gauge. “While our primary focus remains a B2B business model by way of strategic channel partners, there is growing consumer interest which indicates the potential for substantial cash flows from a retail revenue stream as well. We anticipate rapid adoption of our solution, as we see considerable demand for both our wearables as well as our platform.”

Read More:

AI/ML’s $ $FIRZF CEO Appointed to Advisory Board of ST Innovations $ $ $

Posted by AGORACOM at 3:39 PM on Tuesday, March 2nd, 2021
AI/ML Innovations Inc.

TORONTO , March 2, 2021 – AI/ML Innovations Inc. (CSE: AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that Randy Duguay, CEO of AI/ML Innovations Inc., was appointed to the University of Alberta’s ST Innovations Advisory Board in order to provide input and guidance regarding the commercialization of new technologies in the field of digital health innovations.

“The addition of Randy Duguay to this prestigious advisory board is mutually beneficial” said Tim Daniels , Executive Chairman of AI/ML Innovations Inc.

“Randy is able to share his wealth of expertise and experience in the field of digital health by mentoring and advising others, while simultaneously leveraging the human and technological resources of ST Innovations to the benefit of AI/ML Innovations.”

ST Innovations, the business arm of the University of Alberta’s SMART Network, is Alberta’s leading R&D services organization, connecting entrepreneurs with world-class researchers in support of the latest innovation and R&D.

Read More: